Insiders

12:05pm MBX Biosciences, Inc. Announces Board and Committee Changes CI
Jan. 13 Aligos Therapeutics, Inc. Appoints James Hassard as Executive Vice President and Chief Commercial Officer, Effective January 13, 2026 CI
Jan. 12 BioMarin Pharmaceutical Names Arpit Dave Chief Digital and Information Officer MT
Jan. 12 BioMarin Pharmaceutical Inc. Appoints Arpit Davé as Executive Vice President and Chief Digital and Information Officer CI
Jan. 12 Spyre Therapeutics, Inc. Appoints Kate Tansey Chevlen as Chief Commercial Officer CI
Jan. 12 Zymeworks Inc. Announces Management Changes CI
Jan. 08 Praxis Precision Medicines, Inc. Announces Management Changes CI
Jan. 07 SAB Biotherapeutics, Inc. Announces Board Changes ,Effective January 7, 2026 CI
Jan. 07 Viking Therapeutics, Inc. Announces Appointment of Neil Aubuchon as Chief Commercial Officer CI
Jan. 02 Genelux Corporation Announces Change of Chief Medical Officer CI
Jan. 01 Hyphens Pharma International Names Commercial Chief MT
Jan. 01 Hyphens Pharma International Limited Appoints Irene Hsu As Chief Commercial Officer, Effective January 2, 2026 CI
Dec. 23 Dyne Therapeutics, Inc. Announces the Appointment of Vikram Karnani to Its Board of Directors CI
Nov. 24 Amgen Insider Sold Shares Worth $1,058,667, According to a Recent SEC Filing MT
Nov. 14 Amgen Insider Sold Shares Worth $2,317,071, According to a Recent SEC Filing MT
Nov. 12 Autolus Therapeutics plc Appoints Patrick Mcilvenny as Senior Vice President, Finance and Chief Accounting Officer CI
Nov. 12 Immix Biopharma, Inc. Appoints Michael Grabow as Chief Commercial Officer CI
Nov. 10 Nurix Therapeutics, Inc. Appoints Roger Dansey to Its Board of Directors CI
Nov. 06 Coherus Oncology, Inc. Appoints Arvind Sood as Chief Strategy and Corporate Affairs Officer CI
25-10-28 Assertio Holdings, Inc. Announces Chief Executive Officer Changes, Effective October 28, 2025 CI
25-10-27 Agilent Technologies Appoints Adam Elinoff as CFO MT
25-10-27 Agilent Technologies, Inc. Announces Executive Changes CI
25-10-27 Immatics N.V. Appoints Amie Krause as Chief People Officer, Effective October 27, 2025 CI
25-09-30 OSE Immunotherapeutics Approves Board Appointments CI
25-09-16 Immuneering Corporation Appoints Thomas Schall as Chairman of the Board CI
No results for this search